Kathrin Milbury, PhD, assistant professor of Integrative Medicine Research at The University of Texas MD Anderson Cancer Center, discusses caregiver burden in spouses of patients with lung cancer.
Kathrin Milbury, PhD, assistant professor of Integrative Medicine Research at The University of Texas MD Anderson Cancer Center, discusses caregiver burden in spouses of patients with lung cancer.
In a small study analyzing 30 patients with advanced lung cancer and their spouses, Milbury found that spouses overestimated the extent to which patients experience symptoms. When the caregiver becomes hyper-vigilant to the needs of the patient, he or she tends to neglect their own medical needs.
Milbury and other researchers developed interventions using a team approach to help patients and caregivers relate to each other. Emotional support, including listening, physical presence, and expressing love, affection, and care, is the most significant source of support in caregiving, Milbury says.
Milbury says that putting patients in an active role as opposed to being the recipient of support will empower them and give them a sense of purpose in their relationship.
FDA Approves Amivantamab Plus Chemo Combo for Advanced NSCLC With EGFR Exon 20 Insertion Mutations
March 1st 2024Amivantamab was approved by the FDA as first-line treatment of patients with locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations or as therapy for those whose disease progressed on or after platinum-based chemotherapy.
Perioperative Tislelizumab Plus Chemo Improves Event-Free Survival in Resectable NSCLC
March 1st 2024Treatment with neoadjuvant tislelizumab plus platinum-based doublet chemotherapy, followed by surgery and adjuvant tislelizumab, improved event-free survival in patients with resectable non–small cell lung cancer.